(Q37781991)

23 August 2017

title

Recurrence of focal segmental glomerulosclerosis after kidney transplantation: strategies and outcome (English)

1 reference

focal segmental glomerulosclerosis

23 August 2017

main subject

1 reference

based on heuristic

inferred from title

kidney transplantation

1 reference

Tim Ulinski

1

1 reference

23 August 2017

language of work or name

1 reference

1 October 2010

1 reference

full work available at URL

23 August 2017

https://journals.lww.com/10.1097/MOT.0b013e32833dee3a

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E32833DEE3A

Current opinion in organ transplantation

21 June 2024

published in

1 reference

23 August 2017

volume

15

1 reference

23 August 2017

issue

5

1 reference

23 August 2017

page(s)

628-632

1 reference

Recurrence of idiopathic nephrotic syndrome after renal transplantation

23 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E32833DEE3A

21 June 2024

3

20

255

Lagrue

1991

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E32833DEE3A

Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome

21 June 2024

4

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E32833DEE3A

Disease recurrence in paediatric renal transplantation

21 June 2024

5

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E32833DEE3A

Is there a need for a multicenter study to determine the optimal approach to recurrent nephrotic syndrome following renal transplantation?

21 June 2024

6

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E32833DEE3A

Focal segmental glomerulosclerosis

21 June 2024

7

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E32833DEE3A

New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosis.

21 June 2024

8

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E32833DEE3A

Recurrence of focal segmental glomerulosclerosis in transplanted kidneys: analysis of incidence and risk factors in 59 allografts

21 June 2024

9

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E32833DEE3A

Recurrence of focal-segmental glomerulosclerosis in children after renal transplantation: clinical and genetic aspects

21 June 2024

10

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E32833DEE3A

Recurrence of nephrotic syndrome after renal transplantation: influence of increased immunosuppression.

21 June 2024

11

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E32833DEE3A

Recurrence of focal segmental glomerulosclerosis posttransplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study

21 June 2024

12

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E32833DEE3A

Recurrence of primary renal disease on kidney graft: a European pediatric experience

21 June 2024

13

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E32833DEE3A

Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children

21 June 2024

14

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E32833DEE3A

Impact of recurrent nephrotic syndrome after renal transplantation in young patients

21 June 2024

15

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E32833DEE3A

High-dose cyclosporine therapy in recurrent nephrotic syndrome following renal transplantation

21 June 2024

16

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E32833DEE3A

The pediatric nephrotic syndrome spectrum: clinical homogeneity and molecular heterogeneity

21 June 2024

17

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E32833DEE3A

Single-center analysis of early recurrence of nephrotic syndrome following renal transplantation in children

21 June 2024

18

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E32833DEE3A

21 June 2024

19

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E32833DEE3A

Outcomes after renal transplantation for FSGS in children

21 June 2024

20

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E32833DEE3A

Focal segmental glomerulosclerosis: a need for caution in live-related renal transplantation

21 June 2024

21

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E32833DEE3A

NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome

21 June 2024

23

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E32833DEE3A

Broadening the spectrum of diseases related to podocin mutations

21 June 2024

25

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E32833DEE3A

NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence.

21 June 2024

26

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E32833DEE3A

Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin

21 June 2024

27

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E32833DEE3A

Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome.

21 June 2024

28

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E32833DEE3A

Gross proteinuria post transplant in a child with nephrotic syndrome of the Finnish type--mechanical vs immunological pathogenesis

21 June 2024

29

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E32833DEE3A

Long-term outcome of focal segmental glomerulosclerosis after Japanese pediatric renal transplantation

21 June 2024

30

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E32833DEE3A

Intravenous cyclosporine therapy in recurrent nephrotic syndrome after renal transplantation in children.

21 June 2024

31

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E32833DEE3A

Clinical impact of cyclosporine cellular pharmacodynamics in minimal change nephrotic syndrome.

21 June 2024

32

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E32833DEE3A

Early recurrent nephrotic syndrome after renal transplantation in children with focal segmental glomerulosclerosis

21 June 2024

34

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E32833DEE3A

Immunoadsorbtion and rituximab therapy in a second living-related kidney transplant patient with recurrent focal segmental glomerulosclerosis

21 June 2024

35

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E32833DEE3A

Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab

21 June 2024

36

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E32833DEE3A

Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndrome

21 June 2024

37

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E32833DEE3A

Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis

21 June 2024

38

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E32833DEE3A

Rituximab for refractory focal segmental glomerulosclerosis

21 June 2024

39

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E32833DEE3A

Rituximab for post-transplant recurrences of FSGS.

21 June 2024

40

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E32833DEE3A

Treatment of focal segmental glomerular sclerosis with rituximab: 2 case reports

21 June 2024

41

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E32833DEE3A

Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence.

21 June 2024

42

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E32833DEE3A

Use of Rituximab in Focal Glomerulosclerosis Relapses After Renal Transplantation

21 June 2024

43

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E32833DEE3A

Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis

21 June 2024

44

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E32833DEE3A

Rituximab failed to improve nephrotic syndrome in renal transplant patients with recurrent focal segmental glomerulosclerosis

21 June 2024

45

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E32833DEE3A

Rituximab efficiency in children with steroid-dependent nephrotic syndrome

21 June 2024

46

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E32833DEE3A

Successful anti-TNFalpha treatment in a child with posttransplant recurrent focal segmental glomerulosclerosis.

21 June 2024

47

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E32833DEE3A

21 June 2024

Identifiers

1 reference

23 August 2017

1 reference